The impact of COVID-19 on clinical outcomes among acute myocardial infarction patients undergoing early invasive treatment strategy.

ABSTRACT:

Background

The implications of coronavirus disease 2019 (COVID-19) infection on outcomes after invasive therapeutic strategies among patients presenting with acute myocardial infarction (AMI) are not well studied.

Hypothesis

To assess the outcomes of COVID-19 patients presenting with AMI undergoing an early invasive treatment strategy.

Methods

This study was a cross-sectional, retrospective analysis of the National COVID Cohort Collaborative database including all patients presenting with a recorded diagnosis of AMI (ST-elevation myocardial infarction (MI) and non-ST elevation MI). COVID-19 positive patients with AMI were stratified into one of four groups: (1a) patients who had a coronary angiogram with percutaneous coronary intervention (PCI) within 3 days of their

SUBMITTER: Sharma P 

PROVIDER: S-EPMC9538930 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature